- Home
- BMY vs MMC Comparison
BMY vs MMC Comparison
Compare BMY & MMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MMC
- Stock Information
- Founded
- BMY 1887
- MMC 1871
- Country
- BMY United States
- MMC United States
- Employees
- BMY N/A
- MMC N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MMC Specialty Insurers
- Sector
- BMY Health Care
- MMC Finance
- Exchange
- BMY Nasdaq
- MMC Nasdaq
- Market Cap
- BMY 115.3B
- MMC 104.0B
- IPO Year
- BMY N/A
- MMC N/A
- Fundamental
- Price
- BMY $55.84
- MMC $230.04
- Analyst Decision
- BMY Hold
- MMC Hold
- Analyst Count
- BMY 14
- MMC 16
- Target Price
- BMY $58.00
- MMC $231.19
- AVG Volume (30 Days)
- BMY 11.5M
- MMC 2.1M
- Earning Date
- BMY 02-06-2025
- MMC 04-17-2025
- Dividend Yield
- BMY 4.44%
- MMC 1.42%
- EPS Growth
- BMY N/A
- MMC 8.63
- EPS
- BMY N/A
- MMC 8.18
- Revenue
- BMY $48,300,000,000.00
- MMC $24,458,000,000.00
- Revenue This Year
- BMY N/A
- MMC $11.02
- Revenue Next Year
- BMY N/A
- MMC $5.94
- P/E Ratio
- BMY N/A
- MMC $28.11
- Revenue Growth
- BMY 7.32
- MMC 7.57
- 52 Week Low
- BMY $39.35
- MMC $196.17
- 52 Week High
- BMY $61.10
- MMC $235.50
- Technical
- Relative Strength Index (RSI)
- BMY 45.21
- MMC 64.22
- Support Level
- BMY $53.54
- MMC $228.30
- Resistance Level
- BMY $56.54
- MMC $231.72
- Average True Range (ATR)
- BMY 1.41
- MMC 2.95
- MACD
- BMY -0.26
- MMC 0.33
- Stochastic Oscillator
- BMY 33.72
- MMC 89.58
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MMC Marsh & McLennan Companies Inc.
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.